Morgan Stanley Maintains Overweight on MetLife, Raises Price Target to $80
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Nigel Dally has maintained an Overweight rating on MetLife (NYSE:MET) and raised the price target from $79 to $80.
November 02, 2023 | 6:46 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Morgan Stanley has maintained an Overweight rating on MetLife and raised the price target from $79 to $80.
The news is directly related to MetLife as Morgan Stanley has maintained an Overweight rating on the company and raised the price target. This indicates a positive outlook for the company's stock, which could lead to an increase in its price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100